Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting HCC Therapy: On or Off ToPiX?

Literature DB >> 26062821

Targeting HCC Therapy: On or Off ToPiX?

Claudia D Andl¹.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 26062821 PMCID： PMC4518732 DOI： 10.1007/s10620-015-3749-y

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

13 in total

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors: Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal: J Hepatol Date: 2006-06-23 Impact factor: 25.083

2. TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.

Authors: Qingquan Liu; Kangsheng Tu; Hongyong Zhang; Xin Zheng; Yingmin Yao; Qingguang Liu
Journal: Hepatol Res Date: 2014-10-23 Impact factor: 4.288

3. Tpx2 controls spindle integrity, genome stability, and tumor development.

Authors: Cristina Aguirre-Portolés; Alexander W Bird; Anthony Hyman; Marta Cañamero; Ignacio Pérez de Castro; Marcos Malumbres
Journal: Cancer Res Date: 2012-01-20 Impact factor: 12.701

4. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.

Authors: N Wong; P Lai; E Pang; L F Fung; Z Sheng; V Wong; W Wang; Y Hayashi; E Perlman; S Yuna; J W Lau; P J Johnson
Journal: Clin Cancer Res Date: 2000-10 Impact factor: 12.531

5. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.

Authors: Bo Liang; Chunhong Jia; Yu Huang; Hua He; Jialu Li; Hui Liao; Xiao Liu; Xincheng Liu; Xiaochun Bai; Dinghua Yang
Journal: Dig Dis Sci Date: 2015-05-30 Impact factor: 3.199

Review 6. Hepatocellular carcinoma.

Authors: Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal: Lancet Date: 2012-02-20 Impact factor: 79.321

1. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.

Authors: Bo Liang; Wenjuan Zheng; Lu Fang; Linquan Wu; Fan Zhou; Xiangbao Yin; Xin Yu; Zhenhong Zou
Journal: Cancer Biol Ther Date: 2016-06-17 Impact factor: 4.742

1 in total

Targeting HCC Therapy: On or Off ToPiX?

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

2. TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.

3. Tpx2 controls spindle integrity, genome stability, and tumor development.

4. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.

5. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.

Review 6. Hepatocellular carcinoma.

7. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly.

8. Beta-catenin is temporally regulated during normal liver development.

9. Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.

10. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.

1. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.